Conditions: Endometrial Cancer
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 6
Healthy volunteers: no

Brief summary:
The purpose of the protocol is to determine the effect of BN83495 on the progression of endometrial cancer with estrogen receptor in post menopausal women who had previously received chemotherapy.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: BN83495
Intervention descriptions: intervention 1: 1 tablet of 40 mg, oral, daily until progression or death or unacceptable toxicity develops

Protocol document: